Argos Therapeutics Inc (NASDAQ:ARGS) Shareholder Notice: Lawsuit Alleges Misleading Statements
March 23, 2017 at 12:45 PM EDT
San Diego, CA -- (SBWIRE) -- 03/23/2017 -- An investor, who purchased shares of Argos Therapeutics Inc (NASDAQ:ARGS), filed a lawsuit in North Carolina over alleged violations of Federal Securities Laws by Argos Therapeutics Inc.
